Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Dong Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-1821-2741; OpenAlex author ID A5039539227. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 5 papers · 2026: 1 paper

Papers 8

  1. KRAS G12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer. Last author DOI 10.1016/j.ccell.2026.10.003↗
  2. A pancreatic cancer organoid biobank links multi-omics signatures to therapeutic response and clinical evaluation of statin combination therapy. Last author DOI 10.1016/j.stem.2025.07.008↗
  3. Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. Co-author DOI 10.1038/s41467-025-57520-3↗
  4. Clinical functional proteomics of intercellular signalling in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08225-y↗
  5. ODFormer: a Virtual Organoid for Predicting Personalized Therapeutic Responses in Pancreatic Cancer Co-author DOI 10.1101/2025.07.08.663664↗
  6. Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients. Co-author DOI 10.1172/jci.insight.181873↗
  7. Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2023.101162↗
  8. Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity. Last author DOI 10.1038/s41467-022-29857-6↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yunguang Li · 7 shared papers, 2022–2025 · strength 1.20
  2. Gang Jin · 6 shared papers, 2022–2026 · strength 1.04
  3. Xiaohan Shi · 6 shared papers, 2022–2025 · strength 1.00
  4. Yehan Zhang · 5 shared papers, 2022–2026 · strength 0.89
  5. Shiwei Guo · 5 shared papers, 2022–2025 · strength 0.80
  6. Kailian Zheng · 4 shared papers, 2022–2025 · strength 0.67
  7. Suizhi Gao · 3 shared papers, 2022–2025 · strength 0.47
  8. Xiongfei Xu · 3 shared papers, 2022–2025 · strength 0.47
  9. Xiaoyi Yin · 2 shared papers, 2025 · strength 0.35
  10. Zhongjun Wu · 1 shared paper, 2026 · strength 0.23
  11. Lin Wang · 1 shared paper, 2026 · strength 0.23
  12. Yu Shi · 1 shared paper, 2025 · strength 0.20
  13. Peiwu Huang · 1 shared paper, 2025 · strength 0.20
  14. Gang Jin · 1 shared paper, 2025 · strength 0.20
  15. Min Wang · 1 shared paper, 2025 · strength 0.20
  16. Jing Xu · 1 shared paper, 2025 · strength 0.20
  17. Tony R. Hunter · 1 shared paper, 2025 · strength 0.20
  18. Renyi Qin · 1 shared paper, 2025 · strength 0.20
  19. Ruijun Tian · 1 shared paper, 2025 · strength 0.20
  20. Lingyu Zhu · 1 shared paper, 2025 · strength 0.19
  21. Bo Li · 1 shared paper, 2025 · strength 0.19
  22. Eric Tran · 1 shared paper, 2025 · strength 0.19
  23. Chunming Zhang · 1 shared paper, 2025 · strength 0.16
  24. Bin Song · 1 shared paper, 2025 · strength 0.16
  25. Guoxiao Zhang · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.